Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 8/20 | 0.52 |
| ▸ | MGAM | O43451 | 4/20 | 0.52 |
| ▸ | GUSB | P08236 | 2/20 | 0.39 |
| ▸ | GLB1 | P16278 | 1/20 | 0.37 |
| ▸ | GBA1 | P04062 | 4/20 | 0.36 |
| ▸ | SI | P14410 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LCT | P09848 | 1/20 | 0.34 |
| ▸ | GBA2 | Q9HCG7 | 6/20 | 0.34 |
| ▸ | UGCG | Q16739 | 3/20 | 0.34 |
| ▸ | AGL | P35573 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9495730 | 1.00 | GAA (0.52) | GAAMGAMGUSBGLB1GBA1 | |
| SCHEMBL23503287 | 1.00 | GAA (0.52) | GAAMGAMGUSBGLB1GBA1 | |
| SCHEMBL7886644 | 1.00 | GAA (0.52) | GAAMGAMGUSBGLB1GBA1 | |
| SCHEMBL8262448 | 1.00 | GAA (0.52) | GAAMGAMGUSBGLB1GBA1 | |
| SCHEMBL9348141 | 0.92 | — | — | |
| SCHEMBL28068212 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL28276138 | 0.78 | — | — | |
| SCHEMBL7799932 | 0.76 | GAA (0.54) | GAAMGAMGUSBGLB1GBA1 | |
| SCHEMBL8860677 | 0.76 | — | — | |
| SCHEMBL3502688 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010049678-A2 | TREATMENT OF ENERGY UTILIZATION DISEASES | SUMMIT CORPORATION PLC (GB) | 2010-05-06 | — | — | WO | disclosed |